Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8676 |
High Similarity |
NPD3027 |
Phase 3 |
0.8467 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8394 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8357 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8357 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8333 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8214 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7971 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7971 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7939 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7939 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7899 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7887 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7848 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.782 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7812 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7803 |
Intermediate Similarity |
NPD228 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7756 |
Intermediate Similarity |
NPD37 |
Approved |
0.775 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7724 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7722 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7664 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7654 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD1934 |
Approved |
0.761 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.761 |
Intermediate Similarity |
NPD4965 |
Approved |
0.761 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7595 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7589 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7552 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7533 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7519 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7519 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7515 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7515 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.747 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7467 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7466 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7425 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7419 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7391 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7389 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7379 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7355 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7346 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7346 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7321 |
Intermediate Similarity |
NPD7472 |
Approved |
0.732 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD8651 |
Approved |
0.729 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7261 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7248 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7244 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7244 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7237 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7235 |
Intermediate Similarity |
NPD7240 |
Approved |
0.723 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7222 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7193 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7188 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7184 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7168 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD7095 |
Approved |
0.716 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7135 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7132 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7125 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7121 |
Intermediate Similarity |
NPD846 |
Approved |
0.7121 |
Intermediate Similarity |
NPD940 |
Approved |
0.7114 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7114 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7114 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.711 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7076 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7073 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7071 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7063 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7051 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7049 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7045 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7037 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7037 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7032 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7007 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.6994 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6987 |
Remote Similarity |
NPD3060 |
Approved |
0.6981 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD4678 |
Approved |
0.6975 |
Remote Similarity |
NPD4675 |
Approved |
0.6974 |
Remote Similarity |
NPD3657 |
Discovery |
0.6968 |
Remote Similarity |
NPD5762 |
Approved |
0.6968 |
Remote Similarity |
NPD5763 |
Approved |
0.6964 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6964 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6959 |
Remote Similarity |
NPD4624 |
Approved |
0.6954 |
Remote Similarity |
NPD2674 |
Phase 3 |
0.6951 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD3748 |
Approved |
0.6948 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD5494 |
Approved |
0.6944 |
Remote Similarity |
NPD5846 |
Approved |
0.6944 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6943 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD6696 |
Suspended |
0.6937 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6934 |
Remote Similarity |
NPD2684 |
Approved |
0.6933 |
Remote Similarity |
NPD7411 |
Suspended |
0.6928 |
Remote Similarity |
NPD3749 |
Approved |
0.6928 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD1607 |
Approved |
0.6923 |
Remote Similarity |
NPD7037 |
Approved |
0.6923 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD943 |
Approved |
0.6908 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6899 |
Remote Similarity |
NPD2677 |
Approved |
0.6899 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.6899 |
Remote Similarity |
NPD6190 |
Approved |
0.6892 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6882 |
Remote Similarity |
NPD27 |
Approved |
0.6882 |
Remote Similarity |
NPD2489 |
Approved |
0.6875 |
Remote Similarity |
NPD1357 |
Approved |
0.6875 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD4584 |
Approved |
0.6871 |
Remote Similarity |
NPD6582 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.6871 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.6864 |
Remote Similarity |
NPD3051 |
Approved |
0.6863 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6863 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6861 |
Remote Similarity |
NPD2342 |
Discontinued |
0.686
|
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |